new glp 1 drugs in development Novo cuts GLP-1 prices 70%, but semaglutide revenue could grow 2026 The GLP-1 revolution: What UAB

its reactivation in somatic cells could theoretically extend replicative lifespan by maintaining telomere length

2019;40:1425 Toubiana J, Poirault C, Corsia A, et al

5A-1MQ-treated mice switched from WD to LD (WD/LD-T) showed a rather reduced relative abundance of Akkermansia compared to vehicle-treated DIO animals switched from WD to LD (WD/LD-V), suggesting a unique microbiome mechanism associated with weight loss in the vehicle-treated group switched from WD to LD compared to the 5A-1MQ-treated group that underwent the same diet switch

Schonhoff AM, Figge DA, Williams GP, Jurkuvenaite A, Gallups NJ, Childers GM, et al